GlobalData predicts that tirzepatide is likely to be increasingly prescribed for broader cardiometabolic disease.

Bet she 'Made You Look'! Meghan Trainor isn't a gatekeeper and her being transparent about her journey to her dream body is ...

Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its ...

Hims & Hers Health Inc (NYSE:HIMS) shares spiked higher in afternoon trading Tuesday after the company said it will offer Eli ...

Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded ...

Hims & Hers Health (NYSE:HIMS) stock gains as the company adds Eli Lilly's (LLY) weight loss therapy tirzepatide & generic ...

The company’s stock rise reflects investor optimism following the news that Hims & Hers will provide both branded versions of ...

Meghan Trainor revealed her transformation journey involves a mix of lifestyle changes, working with a dietitian, and using ...

Telehealth firm Hims & Hers Health said on Monday it plans to sell Eli Lilly's diabetes and weight-loss drugs on its platform ...

A Prime Therapeutics analysis of real-world data has found that medical costs for patients taking GLP-1 drugs for obesity had increased by about $1,338 per member, compared with a matched control ...

Meghan Trainor opens up about use of weight loss drug after body transformation - ‘It’s a little disheartening that so many ...

Eli Lilly (LLY) is targeting additional drug compounders and telehealth companies that make copycat versions of its weight loss drug, with ...